Extracellular Glutamate-Induced mTORC1 Activation via the IR/IRS/PI3K/Akt Pathway Enhances the Expansion of Porcine Intestinal Stem Cells

被引:34
|
作者
Zhu, Min [1 ]
Qin, Ying-chao [1 ]
Gao, Chun-qi [1 ]
Yan, Hui-chao [1 ]
Li, Xiang-guang [2 ]
Wang, Xiu-qi [1 ]
机构
[1] Natl Engn Res Ctr Breeding Swine Ind, Coll Anim Sci, South China Agr Univ, Guangdong Prov Key Lab Anim Nutr Control, Guangzhou 510642, Guangdong, Peoples R China
[2] Guangdong Univ Technol, Sch Biomed & Pharmaceut Sci, Dept Pharmaceut Engn, Guangzhou 510006, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
mTORC1; IR/IRS/PI3K/Akt; glutamate; intestinal stem cells; organoid; LEUCINE SENSOR; RAG GTPASES; IN-VITRO; GROWTH; PROLIFERATION; SUFFICIENCY; METABOLISM; COMPLEX;
D O I
10.1021/acs.jafc.9b03626
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Glutamate (Glu) is a critical nutritional regulator of intestinal epithelial homeostasis. In addition, intestinal stem cells (ISCs) at crypt bases are known to play important roles in maintaining the renewal and homeostasis of the intestinal epithelium, and the aspects of communication between Glu and ISCs are still unknown. Here, we identify Glu and mammalian target of rapamycin complex 1 (mTORC1) as essential regulators of ISC expansion. The results showed that extracellular Glu promoted ISC expansion, indicated by increased intestinal organoid forming efficiency and budding efficiency as well as cell proliferation marker Ki67 immunofluorescence and differentiation marker Keratin 20 (KRT20) expression. Moreover, the insulin receptor (IR) mediating phosphorylation of the insulin receptor substrate (IRS) and downstream signaling phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway was involved in this response in ISCs. As expected, Glu-induced mTORC1 signaling activation was observed in the intestinal porcine enterocyte cell line (IPEC-J2), and Glu activated the PI3K/Akt/mTORC1 pathway. Accordingly, PI3K inhibition partially suppressed Glu-induced mTORC1 activation. In addition, Glu increased the phosphorylation levels of IR and IRS, and inhibiting IR downregulated the IRS/PI3K/Akt pathway. Collectively, our findings first indicate that extracellular Glu activates mTORC1 via the IR/IRS/PI3K/Akt pathway and stimulates ISC expansion, providing a new perspective for regulating the growth and health of the intestinal epithelium.
引用
收藏
页码:9510 / 9521
页数:12
相关论文
共 50 条
  • [1] Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway
    Nathan, Neera
    Keppler-Noreuil, Kim M.
    Biesecker, Leslie G.
    Moss, Joel
    Darling, Thomas N.
    DERMATOLOGIC CLINICS, 2017, 35 (01) : 51 - +
  • [2] HBSP Ameliorates CCl4-induced Acute Liver Injury by Activation of PI3K/Akt/mTORC1 pathway
    Wu, Shengdi
    Yang, Cheng
    Shen, Xi-Zhong
    HEPATOLOGY, 2016, 64 : 317A - 317A
  • [3] mTORC1 inhibition with rapamycin leads to activation of PI3K/AKT signalling via an mTORC2 dependent mechanism in melanoma cells
    Werzowa, J.
    Pratscher, B.
    Cejka, D.
    Pehamberger, H.
    Wacheck, V.
    EJC SUPPLEMENTS, 2006, 4 (12): : 176 - 177
  • [4] The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
    C Blázquez
    A Chiarlone
    L Bellocchio
    E Resel
    P Pruunsild
    D García-Rincón
    M Sendtner
    T Timmusk
    B Lutz
    I Galve-Roperh
    M Guzmán
    Cell Death & Differentiation, 2015, 22 : 1618 - 1629
  • [5] The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
    Blazquez, C.
    Chiarlone, A.
    Bellocchio, L.
    Resel, E.
    Pruunsild, P.
    Garcia-Rincon, D.
    Sendtner, M.
    Timmusk, T.
    Lutz, B.
    Galve-Roperh, I.
    Guzman, M.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (10): : 1618 - 1629
  • [6] mTORC1 and mTORC2 involvement in activation of MAPK pathway via a PI3K/AKT-dependent feedback loop influences glioblastoma multiforme dissemination
    Albert, Ladislau
    Karsy, Michael
    Gulati, Nicholas
    Geis, Mera D.
    Braun, Alex
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2009, 69
  • [7] SOX2 promotes tumor growth via activation of the PI3K/Akt/mTORC1 signaling pathway in esophageal squamous cell carcinoma
    Gen, Yasuyuki
    Yasui, Kohichiroh
    Kitaichi, Tomoko
    Tomie, Akira
    Ito, Yoshito
    CANCER RESEARCH, 2014, 74 (19)
  • [8] RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
    Weinberg, Mark A.
    ANTI-CANCER DRUGS, 2016, 27 (06) : 475 - 487
  • [9] Neurotrophin-4 induces myelin protein zero expression in cultured Schwann cells via the TrkB/PI3K/Akt/mTORC1 pathway
    Guo, Wei
    Li, Yan
    Sun, Chao
    Duan, Hui-Quan
    Liu, Shen
    Xu, Yun-Qiang
    Feng, Shi-Qing
    ANIMAL CELLS AND SYSTEMS, 2017, 21 (02) : 84 - 92
  • [10] Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention
    Davis, Nicole M.
    Sokolosky, Melissa
    Stadelman, Kristin
    Abrams, Stephen L.
    Libra, Massimo
    Candido, Saverio
    Nicoletti, Ferdinando
    Polesel, Jerry
    Maestro, Roberta
    D'Assoro, Antonino
    Drobot, Lyudmyla
    Rakus, Dariusz
    Gizak, Agnieszka
    Laidler, Piotr
    Dulinska-Litewka, Joanna
    Basecke, Joerg
    Mijatovic, Sanja
    Maksimovic-Ivanic, Danijela
    Montalto, Giuseppe
    Cervello, Melchiorre
    Fitzgerald, Timothy L.
    Demidenko, Zoya N.
    Martelli, Alberto M.
    Cocco, Lucio
    Steelman, Linda S.
    McCubrey, James A.
    ONCOTARGET, 2014, 5 (13) : 4603 - 4650